Kraig Biocraft Laboratories Launches Its Sixth 2025 Spider Silk Production Cycle, Introducing the Next Evolution of Its BAM-1 Alpha Recombinant Silk Platform

Stock Information for ReShape Lifesciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ReShape Lifesciences Inc.

24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business
Turnarounds and 18,000% Growth
Kraig Biocraft Laboratories Secures Usage Rights to Strategic Government-Owned Mulberry Gardens to Support Major Spider Silk Production Expansion
Kraig Biocraft Laboratories Launches Significant Hiring Initiative to Support Expanded Spider Silk Production Footprint in Southeast Asia
24/7 Market News- Kraig Biocraft Laboratories Receives Spider Silk Order from Global Performance Sports Brand, Marking Several Major Milestones
Kraig Biocraft Laboratories Fulfilling Order for Customized Spider Silk Application from Leading Performance Sports Brand
Key Catalysts Emerge in Oncology, Synthetic Biology, and M&A Activity as Markets Open
24/7 Market News- Kraig Labs' Production Program Enters Critical Phase as Initial Spider Silk Deliveries Nears

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.